March 29, 2017
Genetic Engineering and Biotechnology News
“Dysmorphology is the study of human congenital malformations—birth defects—in particular, those affecting the anatomy or form (morphology) of the individual. For decades, physicians have tried to master this diagnostic technique, yet until recently they have most often done so without the use of advanced technology. The FDNA team quickly realized they had found a niche where they could leverage their extensive knowledge and maximize their impact—rare diseases.”
The article “Rare Diseases Get Some Much-Needed Face Time” highlights how FDNA is revolutionizing rare disease diagnostics. FDNA’s advanced technology, including its Face2Gene app, leverages facial recognition and AI to identify genetic syndromes quickly and accurately. This innovation significantly enhances the diagnostic process for rare diseases, allowing for earlier detection and tailored treatment plans. The technology’s ability to analyze facial features and correlate them with genetic disorders offers new hope for patients and families affected by rare conditions. FDNA’s groundbreaking approach is setting a new standard in rare disease diagnostics, emphasizing the importance of technological advancements in healthcare.
